Serial 87892780
Live / Registered — Registered (as of 20 Jul 2021)
What this means for you
Registered since 20 Jul 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87892780
- Registration number
- 6428627
- Mark type
- Design / logo
- Filed
- 25 Apr 2018
- Published for opposition
- 29 Jan 2019
- Registered
- 20 Jul 2021
- Attorney of record
- Yana Gorbach
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of rare protein misfolding disease namely, amyloidosis
Owner
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 30 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 27 Mar 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 27 Mar 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 Mar 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 27 Mar 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 27 Mar 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 20 Jul 2021 — REGISTERED-PRINCIPAL REGISTER
- 15 Jun 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 14 Jun 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 May 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 06 May 2021 — USE AMENDMENT FILED
- 15 May 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 May 2021 — TEAS STATEMENT OF USE RECEIVED